Bifurcation kinetics of drug uptake by Gram-negative bacteria

PLoS One. 2017 Sep 19;12(9):e0184671. doi: 10.1371/journal.pone.0184671. eCollection 2017.

Abstract

Cell envelopes of many bacteria consist of two membranes studded with efflux transporters. Such organization protects bacteria from the environment and gives rise to multidrug resistance. We report a kinetic model that accurately describes the permeation properties of this system. The model predicts complex non-linear patterns of drug uptake complete with a bifurcation, which recapitulate the known experimental anomalies. We introduce two kinetic parameters, the efflux and barrier constants, which replace those of Michaelis and Menten for trans-envelope transport. Both compound permeation and efflux display transitions, which delineate regimes of efficient and inefficient efflux. The first transition is related to saturation of the transporter by the compound and the second one behaves as a bifurcation and involves saturation of the outer membrane barrier. The bifurcation was experimentally observed in live bacteria. We further found that active efflux of a drug can be orders of magnitude faster than its diffusion into a cell and that the efficacy of a drug depends both on its transport properties and therapeutic potency. This analysis reveals novel physical principles in the behavior of the cellular envelope, creates a framework for quantification of small molecule permeation into bacteria, and should invigorate structure-activity studies of novel antibiotics.

MeSH terms

  • Anti-Bacterial Agents / metabolism*
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Outer Membrane Proteins / metabolism
  • Benzimidazoles / metabolism
  • DNA / metabolism
  • Escherichia coli / metabolism
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / growth & development
  • Gram-Negative Bacteria / metabolism*
  • Kinetics
  • Models, Biological*

Substances

  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • Benzimidazoles
  • DNA
  • bisbenzimide ethoxide trihydrochloride

Grants and funding

This work was supported by the award HDTRA1-14-1-0019 from the Department of the Defense, Defense Threat Reduction Agency to HIZ and VVR. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.